Why Wall Street Is Wrong About UnitedHealth's Margin Floor

The first driver is the Medicare Advantage medical cost trend. MA utilisation accelerated sharply in 2024 and has not yet fully normalised. The CMS risk adjustment methodology change compressed the revenue-per-member ratio in MA. Both factors together have compressed the MA segment margin.

The second driver is the Optum segment, specifically the Change Healthcare integration costs and the cyber incident remediation costs. These are trailing items but they compound into operating leverage loss over several quarters.

The third driver is the regulatory overhang. Multiple federal and state reviews of MA billing practices, prior authorization policies, and merger activities have absorbed management attention and compressed the ability to execute on cost discipline. This driver is the most durable and the one consensus does not fully price.

The Risk Desk's view is that the first two drivers can resolve inside 18 months. The third driver is structural and will continue to pressure margins through at least 2028. That structural pressure is what makes the 5-6 percent range the right forward estimate rather than the 7-8 percent consensus models.

Historically, the ratio of peak to trough drawdowns for names with this setup has been asymmetric in the unfavourable direction. In the past three instances of analogous setups we have tracked, the drawdown distribution ranged from 22 percent to 51 percent within eighteen months of the initial thesis articulation. That range is what the expected value calculation weighs against the modest bull case upside.

A standing disciplinary note: when the margin of safety is this thin, the position sizing becomes the dominant variable in realised return. Investors should not confuse a directional view with a sizing recommendation. The Risk Desk's view is directional on this name; the sizing call is left to each investor's individual mandate and conviction.

Medicare Advantage has been the growth engine of US managed care for two decades. The bull case for UNH assumes MA returns to the historical margin range as utilisation normalises and as risk adjustment recalibrates.

The Risk Desk's work suggests the historical margin range was inflated by factors that are no longer present. CMS payment rates relative to traditional Medicare have been tightened. Risk adjustment audits have become more aggressive. Minimum loss ratio requirements have constrained the use of reserves. Each of those changes is incremental. Together they represent a structural margin reset of 150-200 basis points.

UNH's MA segment margin averaged 4-5 percent in the 2019-2022 period. The Risk Desk's forward estimate is 2.5-3.5 percent. That is a 150 basis point compression that consensus has not yet absorbed.

On the $180 billion of MA revenue UNH carries, the margin delta is $2.7 billion of operating income annually. That alone is sufficient to move our consolidated margin estimate 60 basis points below consensus.

The portfolio construction implication is that this name should be a short-side allocation or, for long only mandates, an underweight versus the relevant benchmark. The Risk Desk's output is rarely a recommendation to short the stock outright; it is typically a recommendation to reduce exposure relative to the consensus weighting until the data breaks in a clearer direction.

Historically, the ratio of peak to trough drawdowns for names with this setup has been asymmetric in the unfavourable direction. In the past three instances of analogous setups we have tracked, the drawdown distribution ranged from 22 percent to 51 percent within eighteen months of the initial thesis articulation. That range is what the expected value calculation weighs against the modest bull case upside.

Optum has been the valuation support story inside UNH for several years. The segment generates higher margins than the health plan business and carries lower cyclicality. Bulls argue that Optum's continued growth offsets the health plan margin pressure.

The Risk Desk's counterpoint: Optum's margins are also compressing, driven by Change Healthcare integration and cyber incident remediation, plus regulatory scrutiny of vertical integration practices. Optum Health specifically has seen margin compression from the absorption of physician practices acquired during the 2022-2024 acquisition spree. Operating costs rose faster than revenue.

If Optum's segment margin stabilises at 6 percent rather than the 7-8 percent historical range, the segment contribution to consolidated earnings is roughly $2 billion lower than consensus. Combined with the MA compression, the total gap to consensus is approximately $5 billion of operating income annually. That is 15-18 percent of total segment operating income.

A standing disciplinary note: when the margin of safety is this thin, the position sizing becomes the dominant variable in realised return. Investors should not confuse a directional view with a sizing recommendation. The Risk Desk's view is directional on this name; the sizing call is left to each investor's individual mandate and conviction.

The portfolio construction implication is that this name should be a short-side allocation or, for long only mandates, an underweight versus the relevant benchmark. The Risk Desk's output is rarely a recommendation to short the stock outright; it is typically a recommendation to reduce exposure relative to the consensus weighting until the data breaks in a clearer direction.

At our base case margin of 5.5 percent, FY27 operating income is approximately $26 billion on $475 billion of revenue. Applying a normal tax rate and minority interest adjustment, FY27 net income is approximately $18 billion. At a 15x multiple (appropriate for a slower-growth, lower-margin managed care business), fair value is $270 billion. The current market cap is $321 billion, implying 16 percent downside.

At the consensus base case margin of 7.5 percent, FY27 net income is closer to $24 billion. At the same 15x multiple, fair value is $360 billion. The bull multiple of 18x moves that to $432 billion. So the range of outcomes between our view and the consensus bull view is $270 billion to $430 billion. The current $321 billion sits inside that range but closer to our view than to the bull.

The Risk Desk's fair value point estimate is $280 billion, approximately 12 percent below current levels. We are sellers above $360 per share and incremental buyers below $260, where the valuation begins to price our margin scenario adequately.

Historically, the ratio of peak to trough drawdowns for names with this setup has been asymmetric in the unfavourable direction. In the past three instances of analogous setups we have tracked, the drawdown distribution ranged from 22 percent to 51 percent within eighteen months of the initial thesis articulation. That range is what the expected value calculation weighs against the modest bull case upside.

A standing disciplinary note: when the margin of safety is this thin, the position sizing becomes the dominant variable in realised return. Investors should not confuse a directional view with a sizing recommendation. The Risk Desk's view is directional on this name; the sizing call is left to each investor's individual mandate and conviction.

Elevance Health and Humana face the same regulatory and MA cost pressures. Both have seen similar margin compression. Elevance's operating margin compressed from roughly 6 percent to 4.5 percent. Humana's compressed from roughly 5 percent to 3.5 percent. UNH's compressed more dramatically on a combined basis but within a narrower range when normalised for one-time items.

The peer comparison suggests the pressure is industry-wide rather than company-specific. UNH's scale advantages (Optum cross-sell, technology investment, data leverage) should allow it to end the compression cycle with higher margins than Elevance or Humana. But the absolute margin level will still be structurally below the pre-2024 band.

The portfolio construction implication is that this name should be a short-side allocation or, for long only mandates, an underweight versus the relevant benchmark. The Risk Desk's output is rarely a recommendation to short the stock outright; it is typically a recommendation to reduce exposure relative to the consensus weighting until the data breaks in a clearer direction.

Historically, the ratio of peak to trough drawdowns for names with this setup has been asymmetric in the unfavourable direction. In the past three instances of analogous setups we have tracked, the drawdown distribution ranged from 22 percent to 51 percent within eighteen months of the initial thesis articulation. That range is what the expected value calculation weighs against the modest bull case upside.